Greg has been privileged to work in the Pharmaceutical and Medical Device field for approaching 20 years, the last 15 years in Regulatory Affairs. Prior to founding Plunkett Consulting (hence the name) in 2007, Greg was Regulatory Affairs and Clinical Development Manager for a Melbourne based device/pharmaceutical company and was responsible for all activities relating to the domestic and international registrations, clinical development strategy and trial management. Prior to this role, Greg worked within CSL Limited’s pharmaceutical division (now branded as Seqirus) where he directly managed the registration of Company manufactured and in-licensed pharmaceuticals, including being a founding member of regulatory team responsible for the initial approval of their Influenza Vaccine with the FDA. Previous roles including manufacturing/formulation development and quality assurance/quality control roles.
Greg has directly managed the development of various therapeutic goods, from early pre-clinical evaluation through to marketing approval. He has direct experience in obtaining marketing approval in various jurisdictions, including the Australia, New Zealand, US, Europe, Canada and South East Asia.
Greg has a Bachelor of Applied Science (Monash) and a Masters of Medical Science (University of NSW).